Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $151.94 USD
Change Today +7.33 / 5.07%
Volume 466.8K
As of 3:31 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roger A. Jeffs Ph.D.

Co-Chief Executive Officer, President and Director,United Therapeutics Corporation
AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 2 different industries.

See Board Relationships
53$8,847,891
As of Fiscal Year 2014

Background*

Dr. Roger A. Jeffs, Ph.D. has been the Co-Chief Executive Officer and President of United Therapeutics Corporation since January 1, 2015 and April 2001 respectively. Dr. Jeffs joined United Therapeutics Corporation in September 1998 as Director of Research, Development and Medical and also served as its Chief Operating Officer from April 2001 to December 31, 2014. He served as Vice President of Research, Development and Medical at United Therapeutics Corporation since ...

Read Full Background

Corporate Headquarters*

1040 Spring Street
Silver Spring, Maryland 20910

United States

Phone: 301-608-9292
Fax: 301-608-9291

Board Members Memberships*

2002-Present
Co-Chief Executive Officer, President and Director
2014-Present
Director

Education*

Bachelor's Degree
Duke University
PhD
University of North Carolina

Other Affiliations*

Annual Compensation*

Salary$840,389
Total Annual Compensation$840,389

Stock Options*

All Other Compensation$25,213
Exercised Options395,676
Exercised Options Value$28,302,658
Exercisable Options452,375
Exercisable Options Value$33,911,211
Unexercisable Options392,875
Unexercisable Options Value$21,868,639
Total Value of Options$84,082,508
Total Number of Options1,240,926

Total Compensation*

Total Annual Cash Compensation$1,518,983
Total Short Term Compensation$840,389
Other Long Term Compensation$25,213
Total Calculated Compensation$8,847,891
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UTHR:US $151.99 USD +7.38

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.1M
Jean-Paul Clozel M.D.Founder, Chief Executive Officer and Director
Actelion Ltd.
SFr.2.7M
David L. Hallal Chief Executive Officer and Director
Alexion Pharmaceuticals, Inc.
$696.1K
Mark C. Rohr Chairman of the Board, Chief Executive Officer and President
Celanese Corporation
$1.1M
Shigenobu Maekawa President and Representative Director
Nippon Shinyaku Co. Ltd.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNITED THERAPEUTICS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.